Divya Gopalan

Employment

• Himalaya Global Research Centre Regulatory Associate
  2022 - 2025
• Unichem Laboratories Ltd Pilerne Officer
  2015 - 2016
• Sanofi India Ltd Internship
  2014 - 2015

Education

• Manipal College of Pharmaceutical Sciences Ph.D
  2017 - 2023
• Manipal College of Pharmaceutical Sciences M.Pharm
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• A FUNCTIONALIZED NANOSTRUCTURED LIPID CARRIER FOR ALZHEIMER’S DISEASE
  The Patent Office, Government Of India 2026
  +Save
• Mannose-functionalized liposomal delivery of levamisole and lipopolysaccharide enhances therapeutic responses through tumor-associated macrophage modulation in colon cancer
  International Journal of Biological Macromolecules 2026 DOI: 10.1016/j.ijbiomac.2026.152336
  +Save
• Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy
  Journal of Controlled Release 2022 DOI: 10.1016/J.JCONREL.2022.04.019
  +Save
• Evolving Era of "Sponges": Nanosponges as a Versatile Nanocarrier for the Effective Skin Delivery of Drugs
  Current Pharmaceutical Design 2022 DOI: 10.2174/1381612828666220518090431
  +Save
• QbD-driven HPLC method for the quantification of rivastigmine in rat plasma and brain for pharmacokinetics study
  Journal of Applied Pharmaceutical Science 2022 DOI: 10.7324/JAPS.2022.120606
  +Save
• Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers
  Nanotechnology 2021 DOI: 10.1088/1361-6528/abcdcb
  +Save
• Curcumin nanocrystals attenuate cyclophosphamide-induced testicular toxicity in mice
  Toxicology and Applied Pharmacology 2021 DOI: 10.1016/j.taap.2021.115772
  +Save
• Nose-to-brain drug delivery: Regulatory aspects, clinical trials, patents, and future perspectives
  Direct Nose to Brain Drug Delivery Mechanism Technological Advances Applications and Regulatory Updates 2021 DOI: 10.1016/B978-0-12-822522-6.00023-0
  +Save
• Nose-to-brain drug delivery: Regulatory aspects, clinical trials, patents, and future perspectives
  Direct Nose-to-Brain Drug Delivery 2021 DOI: 10.1016/B978-0-12-822522-6.00023-0
  +Save
• Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
  Life Sciences 2020 DOI: 10.1016/j.lfs.2020.117883
  +Save